503 related articles for article (PubMed ID: 18173357)
1. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.
Jacobson MA; Tan QX; Girling V; Poon C; Van Natta M; Jabs DA; Inokuma M; Maecker HT; Bredt B; Sinclair E;
Clin Infect Dis; 2008 Feb; 46(3):458-66. PubMed ID: 18173357
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
[TBL] [Abstract][Full Text] [Related]
3. Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis.
Jacobson MA; Maecker HT; Orr PL; D'Amico R; Van Natta M; Li XD; Pollard RB; Bredt BM;
J Infect Dis; 2004 Apr; 189(8):1362-73. PubMed ID: 15073672
[TBL] [Abstract][Full Text] [Related]
4. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
Maecker HT; Maino VC
Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
[TBL] [Abstract][Full Text] [Related]
5. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
9. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
Scherrenburg J; Schellens IM; van Baarle D
Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
[TBL] [Abstract][Full Text] [Related]
10. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.
Bunde T; Kirchner A; Hoffmeister B; Habedank D; Hetzer R; Cherepnev G; Proesch S; Reinke P; Volk HD; Lehmkuhl H; Kern F
J Exp Med; 2005 Apr; 201(7):1031-6. PubMed ID: 15795239
[TBL] [Abstract][Full Text] [Related]
11. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
[TBL] [Abstract][Full Text] [Related]
12. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.
Sacre K; Carcelain G; Cassoux N; Fillet AM; Costagliola D; Vittecoq D; Salmon D; Amoura Z; Katlama C; Autran B
J Exp Med; 2005 Jun; 201(12):1999-2010. PubMed ID: 15967826
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D
J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
[TBL] [Abstract][Full Text] [Related]
15. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
Giménez E; Muñoz-Cobo B; Solano C; Amat P; de la Cámara R; Nieto J; López J; Remigia MJ; Garcia-Noblejas A; Navarro D
Transpl Infect Dis; 2015 Jun; 17(3):361-70. PubMed ID: 25850900
[TBL] [Abstract][Full Text] [Related]
16. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
López-Oliva MO; Martinez V; Buitrago A; Jiménez C; Rivas B; Escuin F; Santana MJ; Selgas R; Bellón T
Transplantation; 2014 Apr; 97(8):839-45. PubMed ID: 24345896
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.
Na IK; Letsch A; Guerreiro M; Bauer S; Noack I; Geginat J; Reinke P; Loesch M; Kienapfel H; Thiel E; Volk HD; Scheibenbogen C
J Immunother; 2009; 32(9):907-13. PubMed ID: 19816191
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.
Carbone J; Lanio N; Gallego A; Kern F; Navarro J; Muñoz P; Alonso R; Catalán P; Fernández-Yáñez J; Palomo J; Ruiz M; Fernández-Cruz E; Sarmiento E
J Clin Immunol; 2012 Aug; 32(4):809-19. PubMed ID: 22371292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
